title: The proportion of CD3- CD4+ T-cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L-HES).
authors.forename: G
authors.initials: G
authors.lastname: Helbig
authors.forename: R
authors.initials: R
authors.lastname: Wichary
authors.forename: M
authors.initials: M
authors.lastname: Razny
authors.forename: M
authors.initials: M
authors.lastname: Rodzaj
authors.forename: K
authors.initials: K
authors.lastname: Wozniczka
authors.forename: J
authors.initials: J
authors.lastname: Dziaczkowska-Suszek
authors.forename: S
authors.initials: S
authors.lastname: Kyrcz-Krzemien
mesh_terms: D000328:Adult; D017252:CD3 Complex / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D005434:Flow Cytometry; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D018655:Lymphocyte Count; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*
chemical_list: D017252:CD3 Complex; D005938:Glucocorticoids; D011241:Prednisone